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Abstract 
 
Background: Human immunodeficiency virus (HIV) is a virus that causes Acquired Immunodeficiency Syndrome 
(AIDS) which weaken the human immune system and thus increasing the incidence of sexually transmitted infections 
(STIs) and vice versa. 
Materials and Methods: A retrospective study of STIs in HIV/AIDS patients in Unit Perawatan Intermediate 
Penyakit Infeksi (UPIPI) Dr. Soetomo General Hospital Surabaya was conducted from January 1
st,
 2013 to December 
31
st, 
2014. We examined the number and type of STIs, age distribution, gender, occupation, number of CD4
+
, and 
antiretroviral treatment of patients with HIV/AIDS. The data were presented in a descriptive analysis. 
Results: The percentage of STIs patients was 4.2% (148 of 3.350) of all patients with HIV/AIDS in the UPIPI 
Outpatient Clinic of Dr. Soetomo General Hospital. Most patients were 25-44 years old (70.9%) including 54.7% were 
males, 8.0% were housewives, and 1.4% were students. The five highest prevalence of STIs were condylomata 
acuminate (43.9%), non-specific genital ulcers (11.5%), syphilis (10.7%), genital herpes (10.1%), and scabies (8.1%). 
The sexual predilections consisted of heterosexual (70.9%), homosexual (12.2%), bisexual (2.0%), and no data 
(14.9%). Patients with the number of CD4
+ 
<200 mm
3
 was 52.0% and 79.1% of the patients received ARV therapy. 
Conclusion: STIs and HIV/AIDS were closely related. HIV/AIDS could increase the incidence of STIs and STIs could 
elevate HIV/AIDS. 
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Introduction 
 
Acquired Immunodeficiency Syndrome (AIDS) is a group of symptoms caused by infection with Human 
immunodeficiency virus (HIV) that affects the immune system (Bunker et al., 2010; Uihlein et al., 2012). Based on the 
report of the Directorate General of Disease Control and Environmental Health, Ministry of Health Republic of 
Indonesia, the prevalence of AIDS cases in Indonesia from 1987 to 2014 was 23.41/100,000 population (Kementrian 
Kesehatan Republik Indonesia, 2014). The virus infects CD4+ T cells and thus causes the weakening of a patient’s 
immune system (Bunker et al., 2010). Sexual contact is one of the main ways of HIV transmission since the virus is 
most abundant in the semen, vaginal, and cervical discharge. Transmission of HIV infection through anal intercourse is 
more likely to happen because the rectal mucous membrane is thin and damaged easily (Nasronudin, 2014). There is a 
close relationship between STIs and HIV; the presence of STIs could increase the chance of acquiring and spreading 
HIV infection and so does the presence of HIV infection affects in STIs (Ochom et al., 2017; Tzeng et al., 2013; 
UNAIDS, 2012). 
The life cycle of retroviruses resembles intracellular parasite which means HIV cannot replicate outside of 
human cells. Infection of HIV to the host cell starts with the binding of membrane surface protein and gp120 and the 
virus envelope protein (Moir et al., 2011). One of the membrane surface protein of the host cell is CD4+ protein. The 
number and distribution of these receptors in the host cells have been considered to be capable of limiting the 
susceptibility of the cells to HIV infection. Furthermore, the need of co-receptors in virus entry stage has been found. 
The co-receptors are CCR5 (CC chemokine receptor 5) and CXCR4 (CXC chemokine receptor 4) which contain a 
protein that could facilitate the binding of HIV in vitro (Moir et al., 2011; Xhilaga, 2016). After the gp120 of HIV binds 
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with CD4 and other-receptors, there is a change in gp41 conformation caused by the entry of virus’ peptide to the 
cytoplasm of the host cell (Xhilaga, 2016). The most common HIV is the one that binds to CCR5 (R5 strains), which 
infects macrophages and T cells and characterized by less aggressive growth in vitro. Other strain is the one that binds 
with CXCR4 (X4 strain), which specifically only infects T cells. Latest strategy to improve antiretroviral therapy is to 
develop an agent that capable of preventing HIV entry into host cells (Tzeng et al., 2013). 
The decrease in the cellular immune system of HIV patients is characterized by the declining of T helper 
lymphocytes (CD4+) in HIV patients. The patients will be prone to opportunistic diseases that caused by 
microorganisms such as viruses, fungi, and bacteria, while in normal circumstances, the body should be able to prevent 
the entry of such microorganism (Dewi et al., 2015), and STIs (Bunker et al., 2010; Quader et al., 2017). The clinical 
manifestations of STIs also become unspecific, where it tend to be more lesions with greater size than usual. It also 
tends to recur more often, or instead become persistent (Tzeng et al., 2013). 
 
Materials and Methods 
 
We used a retrospective descriptive as study design to determine the incidence, epidemiology, diagnosis, and 
treatment of STIs in patients with HIV/AIDS. The study populations were patients with HIV/AIDS in the UPIPI 
Outpatient Clinic Dr. Soetomo General Hospital during 2013-2014.The subject of the study were patients with 
HIV/AIDS that were diagnosed with STIs who fulfilled the inclusion and exclusion criteria. The inclusion criteria were 
all patients with HIV/AIDS that were diagnosed with new STI cases, and the exclusion criteria were all patients with 
HIV/AIDS with co-morbidities other than STIs. The diagnosis of HIV/AIDS was based on clinical manifestation 
supported by laboratory examination (Rapid test for HIV). In addition, the diagnosis of STIs was based on clinical 
manifestation and laboratory examination. Data were obtained from medical records of UPIPI Outpatient Clinic Dr. 
Soetomo General Hospital during 2013-2014. Data were evaluated descriptively, and the STIs in this study was just 
new cases. Ethical clearance of this study was given by the Research Ethics Committee of Dr. Soetomo General 
Hospital, Surabaya, Indonesia. 
 
 
Results 
 
 There were a total of 3,550 patients with HIV/AIDS in UPIPI Outpatient Clinic of Dr. Soetomo General 
Hospital during 2013-2014, then 148 patients (4.2%) who had STIs were selected. In 2014 the increased number of 
HIV/AIDS patients was accompanied by an increased number of patients with STIs. The number of HIV/AIDS patients 
in 2013 were 1,665 and 69 (4.1%) of them had STIs. Meanwhile, in 2014, the number of patients with HIV/AIDS had 
increased to 1,885 and 79 (4.2%) of them had STIs.  
Most of the patients with HIV/AIDS and STIs in UPIPI outpatient clinic of Dr. Soetomo General Hospital 
during 2013-2014 were aged between 25-44 years old (70.9%), with the youngest was 19 years old and the oldest was 
73 years old. Male patients had a higher prevalence of having HIV/AIDS with STIs (81 patients, 54.7%) compared to 
female patients (67 patients, 45.3%). Based on the distribution of occupation, most of the patients worked in private 
sector, which was 40 patients (27%), 28 patients were (18.8%) unemployed, 12 patients (8%) were housewives, 5 
patients (3.3%) were factory employees, 4 patients (2.7%) were sales promotion girl, 3 patients (2.0%) were the 
shopkeeper, 2 patients (1.4%) were driver, 2 patients (1.4%) were government employees, 2 patients (1.4%) 
werehousekeepers, 2 patients (1.4%) were farmers, 2 patients were marketing employees (1.4%), 2 patients were a 
student and scholar (1.4%), 2 patients were teachers (1.4%), 1 patient (0.7%) was a soldier, 1 patient (0.7%) was a 
salon employee, 1 patient (0.7%) was an employee of local water companies, 1 patient (0.7%) was a mechanic, 1 
patient (0.7%) was an architect; while 36 patients (24.2%) had no data. 
Based on the data above, the highest cases of STIs in HIV/AIDS patients were condylomata acuminate 
(43.9%), non-specific genital ulcer (11.5%), syphilis (10.7%), genital herpes (10.1%), and scabies (8.1%). Another 
STIs were vulvovaginal candidiasis of 9 cases (6.1%), non-specific genital infections (NSGIs) of 8 cases (5.4%), 
chancroid of 2 cases (1.4%), bacterial vaginosis, gonorrhoea urethritis, molluscum contangiosum and Bartholin cyst for 
each was 1 case (0.7%).  
The sexual predilection of the patients included heterosexual (70.9%), homosexual (12.2%) and bisexual 
(2.0%), while 14.9% had no data. Based on the number of CD4+, there were 148 patients with HIV/AIDS and STIs, 77 
patients (52.0%) had less than 200, 30 patients (20.3%) had CD4+ range from 200-350, 14 patients (9.5%) had more 
than 350, whereas 27 patients (18.2%) had no results of CD4+ count. On the other hand, there were 117 patients 
(79.1%) who received therapy antiretroviral (ARV), while 31 patients (20.9%) did not receive ARV therapy. Each 
patient might have received more than one treatment regarding their STIs.  
Based on the treatment result, 61 patients (41.2%) have not been cured who consisted of 48 patients (32.3%) 
with condylomata acuminate, 3 patients (2.1%) with non-specific genital ulcer, 2 patients (1.4%) with scabies, 7 
patients (4.7%) with syphilis, 1 patient (0.7%) with chancroid. There were four patients (2.7%) who experienced 
recurrence by consisting of genital herpes in 1 patient (0.7%), vulvovaginalis candidiasis in 2 patients (1.3%), and 
condylomata acuminate in 1 patient (0.7%). Seventy-five patients (50.7%) were cured, and 8 patients (5.4%) have no 
data. 
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Discussion 
 
The total number of patients who underwent treatment at UPIPI Outpatient Clinic Dr. Soetomo General Hospital 
during 2013-2014 were 3,550 patients. Then, from all of the HIV/AIDS patients, there were 148 (4.2%) patients with STIs. 
The number of HIV/AIDS patients in 2013 was 1,665 and 69 (4.1%) patients were diagnosed with STIs. Meanwhile, in 
2014, the number of patients with HIV/AIDS had increased to 1,885 accompanied by an increase in patients who were 
diagnosed STIs to79 (4.2%) patients. The relationship between STIs and HIV infection has not yet been fully understood. 
Some studies have proven that STIs could increase the risk of HIV and vice versa, the spread of HIV infection might also 
increase the prevalence and incidence of some STIs (Gap, 2015).  In this study, the largest number from the age group of 
the HIV/AIDS patients with STIs were 105 patients (70.9%) who aged 25-44 years old. It might be caused by the tendency 
of high sexual activity of people aged 25-44 years old. The data were consistent with studies conducted by Tzenget al. in 
2013. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure1: The distribution of STIs patients with HIV/AIDS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: Age distribution of STIs patients with HIV/AIDS. 
 
In this study, the majority of HIV/AIDS patients who experienced STIs were male. These results suggested that 
men might have more activities in outside, this might also lead to more exposure of risk factors compared to women. For 
example, working far from their house/family or even in different cities might force them to visit the prostitution. Other 
factors that might cause a higher number of STIs in male patients with HIV/AIDS was that some cases of STIs in women 
were asymptomatic. According to research data by Tzeng et al. in 2013, 97.4% of patients with HIV/AIDS who have STIs 
were males (Tzeng et al., 2013).  
 Based on their occupation, most HIV/AIDS patients with STIs were private employees. The results of research in 
the Kariadi Hospital, Semarang, Indonesia in 2011 also showed that the highest percentage of patient occupation was 
private employees 21.43% (Nelwan et al., 2015). Regarding the distribution of STIs in HIV/AIDS patients, condylomata 
acuminate has the highest prevalence, which was 65 cases (43.9%). The second highest was non-specific genital ulcers by 
17 cases (11.5%), followed by syphilis in 16 cases (10.7%) and genital herpes in 15 cases (10.1%). Scabies was found in 12 
cases (8.1%), whilst vulvovaginal candidiasis was found in 9 cases (6.1%), non-specific genital infections (NSGIs) in 8 
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cases (5.4%), chancroid in 2 cases (1.4%), while bacterial vaginosis, gonorrhea urethritis, molluscum contagiosum and 
Bartholin’s cyst each was 1 case (0.7%).The results were different from a previous study done by Tzeng et al. in 2013which 
showed that the highest STI was Chlamydia (Tzeng et al., 2013). Chlamydia has symptoms that not typical and often 
regarded as a non-specific infection. The diagnosis of chlamydia also requires specific laboratory tests. Chun and his 
colleagues in 2013 said that there was a relationship between the numbers of HIV patients with increased HPV infection. 
The risk of being infected by HPV was increased 30 times in HIV patients with clinical manifestations of genital warts that 
develop into larger sizes and could be caused by multiple HPV sub-types. HPV infection in HIV patients also easily turn 
into cervical and anal cancers. The study also found that the incidence of HSV-infected patients increases in accordance 
with the increase of HIV infections (Chun et al., 2013). Most of HIV patients with HSV have manifestations of genital 
ulcers. Thus, the examination should be supported with genital ulcer history, physical examination and appropriate 
laboratory evaluation, because some STIs also has genital ulcer manifestations (Chun et al., 2013; Goff et al., 2014). 
Syphilis was the second most STIs in HIV patients also manifest as genital ulcers. Various studies have found an 
association between an increasing number of syphilis patients and the number of HIV patients. It was strongly associated 
with a decrease in the number of CD4+ which less than 200 mm3. HIV patients with a number of CD4+ less than 200 mm3 
might have an increase in the incidences of syphilis. Some studies have found increased levels of CD4+ in patients after 
syphilis therapy (Chun et al., 2013). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: The five largest types of STIs in patients with HIV/AIDS 
 
The results showed that most of the sexual predilection of the patients were heterosexual, followed by 
homosexual and bisexual. It might bedue to the STIs in women usually has been asymptomatic that might lead them to 
keep the tendency to switch partners so it increases transmission of STIs. According to Tzeng and his colleagues in 2013, 
most patients who have STIs were heterosexual (Tzeng et al., 2013). Hames and his colleagues said that homosexuality 
increased the risk of transmission of STIs, but most patients tended not to disclose their sexual behaviour (Hamish et al., 
2016). Astindari’s retrospective study on “How HIV/AIDS are Transmitted” were carried out in UPIPI during 2006-2010, 
and it was said that there was a change in the pattern of HIV transmission, which was originally highest by injecting drug 
users (IDUs) in 2005 became by heterosexual sexual intercourse in 2010. According to the Ministry of the Health Republic 
of Indonesia, the pattern of the spread of HIV/AIDS in Indonesia is also changing. In early of 1987, most of HIV 
transmissions were through heterosexual sexual intercourse. Along with the increase in IDUs in Indonesia since 1999 then 
the modes of transmission of HIV/AIDS were also shifted to IDUs. It was due to the reuse of needles that could increase 
the risk of disease transmission. Since 2008, the pattern of transmission of HIV/AIDS has shifted back to heterosexual 
sexual intercourse (Astindari et al., 2011). Also in Dr. Soetomo General Hospital, since 2006-2010 it was found a mode of 
transmission mainly through heterosexual intercourse. In male patients, a shift of mode of transmission of drug use to 
heterosexual sexual intercourse happened since 2008, and the mode of transmission through IDUs continues to drop since 
2008. The decrease was due to the increase of awareness to not reuse needles amongst IDUs. But we need to be aware of 
transmissions in low-risk populations and the increase of STIs prevalence through sexual transmission (Astindari et al., 
2011, Kementrian Kesehatan Republik Indonesia, 2014). Perinatal transmission was increasing in 2006 from 5 people 
(1.3%) to 24 (3.4%) in 2010, that showed more cases of infants acquiring HIV infection from their mothers. Therefore, 
prevention of perinatal transmission needs to be done, such as early diagnosis of HIV infection in pregnant women to 
maximize treatment options in pregnancy and optimize the time of therapy, planning birth by cesarean section, and 
breastfeeding planning. That will affect efforts to prevent the spread of HIV/AIDS. Additionally, we need to be aware of 
the possibility of increased cases of STIs (Abdulai et al., 2017; Astindari et al., 2011). 
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Figure 4: The sexual partner distribution of STIs patients withHIV/AIDS 
 
There was a close relationship between the low number of CD4+ with the increasing incidence of STIs (Furtado 
et al., 1999; UNICEF, 2012). Syphilis infection in HIV patients was associated with increased viral load and decreased of 
the CD4+ count. The increasing of viral load occurs mainly in patients with secondary syphilis infection. In a study of 76 
participants, 33.3% showed an increase in viral load during syphilis infection. Forty-four patients had an overall viral load 
suppression before they were diagnosed with syphilis and eleven (25%) of them showed a detectable viral load after they 
got infected. Nonetheless, the only confirmed factor associated with increased viral load was the absence of ART. It was 
also discovered that there a significant decrease in CD4+count in patients who recently got infected with syphilis compared 
to CD4+ count before the infection. The study also showed the decrease of the CD4
+
 count in 76 patients when compared to 
between before and during the syphilis infection (590:496; p=0.0001). Moreover, 94 patients with syphilis infection showed 
the increase of the CD4
+
 count after they were treated (509:597; p=0.0001) (Buchacz et al., 2004). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5: CD4+ of STIs patients with HIV/AIDS 
 
The appearance of new lesions in condylomata acuminate was associated with the cellular immunity of the 
patient. This was supported by research conducted by Sung and his colleagues that showed a higher prevalence of HPV 
infections, including anal condylomata acuminate in patients with ongoing immunosuppressant therapy and HIV infected 
patients. CD4+ is a very good indicator to measure the immune condition of HIV patients. The low number of CD4+ was 
found in patients with recurrent condylomata acuminate (Lacey et al., 2011). ARV therapy was given in UPIPI following 
WHO's recommendations which included in giving of tenofovir, lamivudine, and efavirenz. Management of STIs in 
patients with HIV/AIDS was equally necessary to overcome the disease in general by giving antiretroviral drugs to patients 
with HIV/AIDS; the incidence of STIs will become rarer. 
No significant difference of number was found regarding the recovery between treated and untreated patients. It 
might be caused by the fact the patients were treated in many different outpatient clinics other than Dermatovenerology 
alone, therefore it was required patience in carrying outpatient therapies. The recurrence rates were also associated with 
HIV infection and AIDS, thus that condition will increase the recurrence (Rompalo et al., 2008, Workowski et al., 2008). 
The limitation of this study was theuse of retrospective studies as astudy design. Furthermore, it requires further 
prospective cohort analytic study to confirm the correlation between HIV/AIDS and STIs. 
 
 
 
 
88 
 
Conclusion 
 
STIs and HIV/AIDS were closely related. HIV/AIDS could increase the incidence of STIs and vice-versa, the 
increasing of STIs could elevate HIV/AIDS. The age group with high sexual activity will be in high risk for STIs, 
especially in HIV patients.  The CD4+ level was associated with increasing number of STIs in HIV patients. 
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